Drugmaker Regeneron Pharmaceuticals is acquiring majority assets of bankrupt genetic testing firm 23andMe Holding for $256 million. The once-sizzling DNA-testing startup filed for bankruptcy in March, ...

Startups are working to overcome clinical concerns with direct-to-consumer genetic testing, according to Business Insider. 1. There are two main ways to access genetic testing — an expensive, complete ...

The "Direct-to-Consumer Genetic Testing Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The direct-to-consumer genetic testing market is undergoing ...

23andMe Research Institute today announced the publication of a new study highlighting the positive health actions taken by people who learned of their risk through direct-to-consumer genetic testing.

Direct-to-consumer gene tests like Ancestry.com and 23andMe are increasingly informing consumers about gene alterations that could signal health risks. But those tests look at only a few positions on ...